inflammatory rheumatological syndrome
pain and stiffness: neck, shoulder, pelvic girdle
worse in morning
lasts ≥1hr
maybe accompanied by systemic features:
fever
fatigue
anoreixa
onset = 2wk - 2mo
-
incidence increase with age
-
average age of onset = 70yo
- rarely \<50yo
-
european descent
-
F>M 2:1
-
50/100000 people over 50yo
-
closely associated with GCA
- but 2-3 times more common
-
genetic and external factors
-
ruling out other illnesses more important than immediately treating
-
cancers
-
insidious onset RA
-
Diagnosis
ruling in (compared to ruling out)
Inclusion
-
Age >50yo
-
symptom duration >2wk
-
bilateral shoulder or pelvic girdle aching - or both
-
Morning stiffness duration >45min
-
Evidence of acute phase response
exclusion
-
infection
-
malignancy
-
GCA
presentation
Pain
-
shoulder pain 70-95%
-
hip and neck = 50-70%
-
upper arm pain common
-
usually biltarel and symmetrical
- may be worse on one side early in the course
-
worsen with movement
-
radiate -> elbows/knees
-
tenderness
- synovial/bursal inflammation
-
weakness not a feature but may be difficult to distinguish this compared to pain
Stiffness
-
morning stiffness that persists for at least 45min
-
may be difficulty with ADL
systemic features
-
1/3
-
low grade fever
-
malaise
-
anorexia
-
weight loss
Peripheral symptoms
-
pain/stiffness joints hands and feet = 50%
-
consider other conditions
concurrent Giant cell arteritis
-
unilateral temporal headaches
-
scalp tenderness
-
jaw claudication
-
visual symptoms
DDx
-
Giant cell arteritis
-
malignancy
-
RA and other arthritidies
-
Endocrine/iatrogenic causes of prox. myopathy
-
hypothyroidism
-
Cushing’s disease
-
statin- induced myopathy/myalgia
-
-
OA
-
SLE/polymyositis
-
Gibromyalgia and localised causes of pain
-
Occult infection
- Subacute bacterial endocarditis
Atypical features
-
age \<60yo
-
chroinc onset
-
lack of shoulder involvement
-
muscle weakness
-
peripheral joint disease
-
predominance of pain with little or no stiffness
-
very high or normal CRP
-
prominent systemic features
-
lack of response to trial dose of prednisone
Investigations
-
CRP
-
noraml acute phase response doens’t rule out PMR
-
CRP alone likely to be sufficient in most people
-
-
FBC
-
most have mild-moderate anaemia
-
elevated WBC and platelet
-
-
LFTs
-
1/3 have mildly abnormal LFTs
- ALP
-
-
Cr and electrolytes
-
consider:
-
TSH
-
RF/anti-CCP
-
Serum electrophoresis
-
CK
-
ANA
-
Treatment
-
corticosteroids = first line
-
plus Vit D
-
consider bisphosphonates
-
PPI
Prednisone 15mg od for 3 weeks
in morning with food
Prednisone 12.5mg od for 3 weeks
Prednisone 10mg OD for 4-6wks
1mg every 4-8wks
measure CRP @ 4 weeks (should normalise)
if symptoms patient returns to previous steroid dose
low dose ‘tail’ need to be very gradual in some people to prevent symptom recurrence
may need low does 2-3yrs
-
after 2 relapses consider DMARD
- methotrexate
-
in general taper dose 10% every 2-4 weeks